Owase Jeelani
Paediatric Neurosurgeon and Co-Founder, Klay Biotech

Owase Jeelani

Owase Jeelani, is a World-renowned Paediatric Neurosurgeon, inventor, entrepreneur, and philanthropist. The Time Magazine ranked him as among the top 100 surgeons in the UK in 2011 and top 100 paediatric specialists in the UK in 2012. His endeavours are designed around optimal prediction algorithms which increase efficiency, limit errors and improve outcomes.

He has worked at Great Ormond Street Hospital (GOSH) part-time since 2000 and full-time since 2009 and he undertakes 200-300 paediatric neurosurgical and craniofacial surgeries annually. His sub speciality interests are Craniofacial Reconstructive Surgery, Craniopagus Separation Surgery, Surgery for Brain Tumours and Cerebrospinal Fluid and Intracranial Pressure Pathologies.

Mr Jeelani was Head of the Department of Neurosurgery at GOSH from 2012 – 2018. He established it as a flagship service and one of the largest paediatric neurosurgery services in the world.

Mr Jeelani is the Founder of Gemini Untwined, a global charity dedicated to the research and treatment of craniopagus twins and other complex craniofacial and neurosurgical conditions.

Owase Jeelani has received international recognition for separating craniopagus twins, including Sudanese twins Rital and Ritag in 2011 and then, through Gemini Untwined, Pakistani twins Safa and Marwa in 2019 (BBC News coverage of Safa and Marwa ranked as the 6th most read news item globally in 2019), Turkish twins, Yigit and Derman in 2020, a set of Israeli twins in 2021 and a set of Brazilian Twins in 2022.

Mr Jeelani undertook his medical training at the University of Nottingham and specialist Neurosurgical and Craniofacial training in the UK and Canada.

He also holds an MPhil in Medical Law from the University of Glasgow and an MBA from INSEAD, studying in France, Singapore, and the Wharton Business School in Philadelphia.

In 2013, Owase Jeelani co-founded the London Craniofacial Unit to benefit patients with craniofacial and neurosurgical issues globally and replicate GOSH’s standard of care in the private sector.